HeartSciences (HSCS) Accounts Payables (2022 - 2026)

HeartSciences has reported Accounts Payables for 5 years, with the latest figure at $410727.0 in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 1.4% year-over-year to $410727.0; the trailing twelve-month figure through Jan 2026 stood at $410727.0 (up 1.4% YoY), and the FY2025 full-year result was $318661.0, down 28.9% from the prior year.
• Accounts Payables for Q1 2026 stood at $410727.0, up from $317390.0 in the prior quarter.
• The five-year high for Accounts Payables was $1.1 million in Q4 2023, with the low at $276848.0 in Q4 2024.
• Historically, Accounts Payables has averaged $527040.0 across 5 years, with a median of $431629.5 in 2024.
• Annual changes were most pronounced in 2023 — Accounts Payables surged 36.85% — and 2024, when it plunged 74.56%.
• HeartSciences' Accounts Payables stood at $795266.0 in 2022, then surged by 36.85% to $1.1 million in 2023, then sank by 74.56% to $276848.0 in 2024, then climbed by 14.64% to $317390.0 in 2025, then gained by 29.41% to $410727.0 in 2026.
• The last three Accounts Payables figures came in at $410727.0 (Q1 2026), $317390.0 (Q4 2025), and $283225.0 (Q3 2025), per Business Quant data.